In addition to the frequent PIK3CA mutations, deletions of PTEN have been observed in about 20% of ovarian clear cell carcinomas, thus supporting a role for aberrant PI3K/PTEN pathway in the development of this tumor. This evidence concerns the gene PIK3CA and ovarian clear cell cancer.